- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting obesity-related dysfunction in hormonally driven cancers
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-28
DOI
10.1038/s41416-021-01393-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The microbiome and gynaecological cancer development, prevention and therapy
- (2020) Paweł Łaniewski et al. Nature Reviews Urology
- Confusion in the nomenclature of ketogenic diets blurs evidence
- (2020) Pierpaolo Trimboli et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?
- (2020) Dominik Ternes et al. TRENDS IN MICROBIOLOGY
- Fiber consumption and breast cancer incidence: A systematic review and meta-analysis of prospective studies
- (2020) Maryam S. Farvid et al. CANCER
- Ketotherapy as an epigenetic modifier in cancer
- (2020) Borja Bandera-Merchan et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies
- (2020) Giuseppina Augimeri et al. Cancers
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features
- (2019) Eva Benabou et al. CANCER LETTERS
- Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903
- (2019) Linda Mileshkin et al. GYNECOLOGIC ONCOLOGY
- Circulating adipokines and risk of obesity related cancers: A systematic review and meta-analysis
- (2019) Yeong Sook Yoon et al. Obesity Research & Clinical Practice
- The Impact of Bariatric Surgery on Breast Cancer Recurrence: Case Series and Review of Literature
- (2019) Shijia Zhang et al. OBESITY SURGERY
- Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms
- (2019) Dimiter Avtanski et al. CYTOKINE
- Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens
- (2019) Samantha M. Ervin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity
- (2019) Sajoux et al. Nutrients
- Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
- (2019) Maria M. Rubinstein et al. CANCER
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer
- (2018) Amit Oza et al. GYNECOLOGIC ONCOLOGY
- OUP accepted manuscript
- (2018) JOURNAL OF NUTRITION
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
- (2018) John B. Allard et al. Frontiers in Endocrinology
- A first-in-human phase 1 dose-escalation trial of the oral HIF-2a inhibitor PT2977 in patients with advanced solid tumors.
- (2018) Kyriakos P. Papadopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib + pembrolizumab in patients with advanced endometrial cancer: Updated results.
- (2018) Vicky Makker et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
- (2018) Benjamin D. Hopkins et al. NATURE
- Lifestyle and Breast Cancer Recurrences: The DIANA-5 Trial
- (2018) Anna Villarini et al. TUMORI
- LBA29CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer
- (2018) A H Ko et al. ANNALS OF ONCOLOGY
- PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a multi-center, randomized double-blind, placebo-controlled phase 3 trial
- (2018) Sarah Kitson et al. CLINICAL CANCER RESEARCH
- The obese adipose tissue microenvironment in cancer development and progression
- (2018) Daniela F. Quail et al. Nature Reviews Endocrinology
- The role of hypoxia-inducible factors in metabolic diseases
- (2018) Frank J. Gonzalez et al. Nature Reviews Endocrinology
- A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study
- (2018) Begoña Martin-Castillo et al. Oncotarget
- Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index
- (2018) Neil M. Iyengar et al. JAMA Oncology
- Insulin Receptor Isoforms in Physiology and Disease: An Updated View
- (2017) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K/AKT/mTOR signaling
- (2017) Yan Zhao et al. GYNECOLOGICAL ENDOCRINOLOGY
- Aromatase inhibitor use during ovarian stimulation suppresses growth of uterine endometrial cancer in xenograft mouse model
- (2017) Tai Kawahara et al. HUMAN REPRODUCTION
- Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity–breast cancer link
- (2017) H Zahid et al. INTERNATIONAL JOURNAL OF OBESITY
- Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells
- (2017) Chi-Cheng Lu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Des-acyl ghrelin inhibits the capacity of macrophages to stimulate the expression of aromatase in breast adipose stromal cells
- (2017) CheukMan C. Au et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Adipose-Derived VEGF–mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women
- (2017) Subhransu S. Sahoo et al. MOLECULAR CANCER RESEARCH
- Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties
- (2017) C-H Wang et al. ONCOGENE
- Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials
- (2017) Amir Zahra et al. RADIATION RESEARCH
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
- (2017) Aaron Simpson et al. Targeted Oncology
- Measuring the biological effect of presurgical metformin treatment in endometrial cancer
- (2016) V N Sivalingam et al. BRITISH JOURNAL OF CANCER
- Physical Activity and Cancer Outcomes: A Precision Medicine Approach
- (2016) C. M. Friedenreich et al. CLINICAL CANCER RESEARCH
- Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study
- (2016) Pamela T. Soliman et al. GYNECOLOGIC ONCOLOGY
- Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer
- (2016) Dongge Cai et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma
- (2016) Clare A. Flannery et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Body composition changes after very low-calorie-ketogenic diet in obesity evaluated by three standardized methods
- (2016) Diego Gomez-Arbelaez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
- (2016) Michaela A. Onstad et al. JOURNAL OF CLINICAL ONCOLOGY
- Weight Loss Randomized Intervention Trials in Female Cancer Survivors
- (2016) Rowan T. Chlebowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study
- (2016) Maura Harrigan et al. JOURNAL OF CLINICAL ONCOLOGY
- Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
- (2016) Neil M. Iyengar et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Body Fatness and Cancer — Viewpoint of the IARC Working Group
- (2016) Béatrice Lauby-Secretan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis
- (2016) B. Cabia et al. Obesity Reviews
- Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression
- (2016) P. Ferroni et al. ONCOLOGIST
- Bevacizumab in ovarian cancer: A critical review of phase III studies
- (2016) Luigi Rossi et al. Oncotarget
- Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women’s Health Initiative: A Longitudinal Study from the United States
- (2016) Melina Arnold et al. PLOS MEDICINE
- Effects of Exercise Amount and Intensity on Abdominal Obesity and Glucose Tolerance in Obese Adults
- (2015) Robert Ross et al. ANNALS OF INTERNAL MEDICINE
- A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial†
- (2015) C. S. Fuchs et al. ANNALS OF ONCOLOGY
- Abstract S5-08: Final survival analysis from the randomized Women's Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy
- (2015) Rowan T Chlebowski et al. CANCER RESEARCH
- Prostaglandin E2 Inhibits p53 in Human Breast Adipose Stromal Cells: A Novel Mechanism for the Regulation of Aromatase in Obesity and Breast Cancer
- (2015) X. Wang et al. CANCER RESEARCH
- p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis
- (2015) X. Wang et al. CANCER RESEARCH
- Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy
- (2015) W. J. Gradishar et al. CLINICAL CANCER RESEARCH
- FDA Approval Summary: Lenvatinib for Progressive, Radio-iodine-Refractory Differentiated Thyroid Cancer
- (2015) A. Nair et al. CLINICAL CANCER RESEARCH
- Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer
- (2015) N. M. Iyengar et al. CLINICAL CANCER RESEARCH
- Secreted factors derived from obese visceral adipose tissue regulate the expression of breast malignant transformation genes
- (2015) A B Crujeiras et al. INTERNATIONAL JOURNAL OF OBESITY
- A novel leptin antagonist peptide inhibits breast cancer growthin vitroandin vivo
- (2015) Stefania Catalano et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors
- (2015) Cheryl L. Rock et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
- (2015) Brian M. Slomovitz et al. JOURNAL OF CLINICAL ONCOLOGY
- A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory,KRASWild-Type, Metastatic Colorectal Cancer
- (2015) Francesco Sclafani et al. JNCI-Journal of the National Cancer Institute
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
- (2015) Martin Fassnacht et al. LANCET ONCOLOGY
- Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor
- (2015) A. Forest et al. MOLECULAR CANCER RESEARCH
- Cancer and the gut microbiota: An unexpected link
- (2015) Laurence Zitvogel et al. Science Translational Medicine
- Obesity and cancer, a case for insulin signaling
- (2015) Y Poloz et al. Cell Death & Disease
- A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory,KRASWild-Type, Metastatic Colorectal Cancer
- (2015) Francesco Sclafani et al. JNCI-Journal of the National Cancer Institute
- Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation
- (2015) Susan M. Farabaugh et al. Frontiers in Endocrinology
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Ghrelin and des-acyl ghrelin inhibit aromatase expression and activity in human adipose stromal cells: suppression of cAMP as a possible mechanism
- (2014) Maria M. Docanto et al. BREAST CANCER RESEARCH AND TREATMENT
- Daughters and Mothers Against Breast Cancer (DAMES): Main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters
- (2014) Wendy Demark-Wahnefried et al. CANCER
- GPER Mediates Activation of HIF1 /VEGF Signaling by Estrogens
- (2014) E. M. De Francesco et al. CANCER RESEARCH
- Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population
- (2014) Morgan E. Levine et al. Cell Metabolism
- Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors
- (2014) P. Haluska et al. CLINICAL CANCER RESEARCH
- Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer
- (2014) Katrina N. Slaughter et al. GYNECOLOGIC ONCOLOGY
- Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non–Small-Cell Lung Cancer
- (2014) Corey J. Langer et al. JOURNAL OF CLINICAL ONCOLOGY
- Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer
- (2014) T N Tran et al. JOURNAL OF CLINICAL PATHOLOGY
- Dietary Fat Intake and Development of Specific Breast Cancer Subtypes
- (2014) Sabina Sieri et al. JNCI-Journal of the National Cancer Institute
- Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
- (2014) Edward B Garon et al. LANCET
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Improved Survival with Bevacizumab in Advanced Cervical Cancer
- (2014) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight loss intervention trials in women with breast cancer: a systematic review
- (2014) M. M. Reeves et al. Obesity Reviews
- Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
- (2014) Altaf Mohammed et al. Translational Oncology
- A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer
- (2014) Edward H. Lin et al. Cancer Medicine
- Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
- (2014) Kevin M. Schuler et al. Cancer Medicine
- The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial
- (2014) Antonio M. Lerario et al. Hormones & Cancer
- Involvement of early growth response factors in TNFα-induced aromatase expression in breast adipose
- (2013) Sarah Q. To et al. BREAST CANCER RESEARCH AND TREATMENT
- Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
- (2013) Woondong Jeong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Neoadjuvant treatment of endometrial cancer using anastrozole: A randomised pilot study
- (2013) Amudha Thangavelu et al. GYNECOLOGIC ONCOLOGY
- A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
- (2013) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial
- (2013) John FR Robertson et al. LANCET ONCOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Effect of dietary composition of weight loss diets on high-sensitivity c-reactive protein: The Randomized POUNDS LOST trial
- (2013) Jacinda M. Nicklas et al. Obesity
- Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity
- (2013) Serena Beccari et al. PEPTIDES
- Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners
- (2013) Rive Sarfstein et al. PLoS One
- Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth
- (2013) Chun-Fang Wang et al. PLoS One
- Statin use and risk of breast cancer: a meta-analysis of observational studies
- (2012) Krishna Undela et al. BREAST CANCER RESEARCH AND TREATMENT
- Leptin Mediates Tumor-Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells
- (2012) I. Barone et al. CANCER RESEARCH
- Integrating Metabolism and Longevity Through Insulin and IGF1 Signaling
- (2012) Marianna Sadagurski et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced-Calorie Dietary Weight Loss, Exercise, and Sex Hormones in Postmenopausal Women: Randomized Controlled Trial
- (2012) Kristin L. Campbell et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Statin Use and Reduced Cancer-Related Mortality
- (2012) Sune F. Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
- (2011) Patrick G. Morris et al. Cancer Prevention Research
- Adiponectin Is Required for PPARγ-Mediated Improvement of Endothelial Function in Diabetic Mice
- (2011) Wing Tak Wong et al. Cell Metabolism
- Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women
- (2011) C. M. Friedenreich et al. ENDOCRINE-RELATED CANCER
- Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
- (2011) T. P. Ahern et al. JNCI-Journal of the National Cancer Institute
- Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
- (2011) H Werner ONCOGENE
- Promoter-specific effects of metformin on aromatase transcript expression
- (2011) Nirukshi U. Samarajeewa et al. STEROIDS
- Aromatase, breast cancer and obesity: a complex interaction
- (2011) Serdar E. Bulun et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Obesity, insulin resistance and free fatty acids
- (2011) Guenther Boden Current Opinion in Endocrinology Diabetes and Obesity
- Visceral adiposity, insulin resistance and cancer risk
- (2011) Claire L Donohoe et al. Diabetology & Metabolic Syndrome
- HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
- (2010) Yoshifumi Baba et al. AMERICAN JOURNAL OF PATHOLOGY
- Macrophages, Inflammation, and Insulin Resistance
- (2010) Jerrold M. Olefsky et al. Annual Review of Physiology
- The PI3K signaling pathway mediates the biological effects of leptin
- (2010) Jose Donato Jr. et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
- (2010) Kristy A. Brown et al. BREAST CANCER RESEARCH AND TREATMENT
- The German SUCCESS C Study – The First European Lifestyle Study on Breast Cancer
- (2010) Brigitte Rack et al. Breast Care
- Adolescent Diet in Relation to Breast Cancer Risk among Premenopausal Women
- (2010) E. Linos et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
- (2010) R. M. Memmott et al. Cancer Prevention Research
- Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells
- (2010) Chiara Laezza et al. ENDOCRINE-RELATED CANCER
- Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial
- (2010) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
- (2010) Catherine Duggan et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer
- (2010) Andrzej Badzio et al. Journal of Thoracic Oncology
- Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study
- (2010) Lucio Crinò et al. LANCET ONCOLOGY
- Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
- (2010) E. Buck et al. MOLECULAR CANCER THERAPEUTICS
- Obesity and Cancer
- (2010) K. Y. Wolin et al. ONCOLOGIST
- Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
- (2009) R. C.M. van Kruijsdijk et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Subcellular Localization of Cyclic AMP-Responsive Element Binding Protein-Regulated Transcription Coactivator 2 Provides a Link between Obesity and Breast Cancer in Postmenopausal Women
- (2009) Kristy A. Brown et al. CANCER RESEARCH
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer
- (2009) B. Guiu et al. GUT
- Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial
- (2009) Lars Sjöström et al. LANCET ONCOLOGY
- Statins and Cancer Risk
- (2008) Igor Karp et al. AMERICAN JOURNAL OF MEDICINE
- Effects of adiponectin on breast cancer cell growth and signaling
- (2008) M E Grossmann et al. BRITISH JOURNAL OF CANCER
- Estrogen Receptor-Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users
- (2008) A. S. Kumar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Balance of adiponectin and leptin modulates breast cancer cell growth
- (2008) Michael E Grossmann et al. CELL RESEARCH
- The Colon Health and Life-Long Exercise Change (CHALLENGE) trial (CO.21)
- (2008) Kerry S. Courneya et al. Current Oncology
- IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons
- (2008) S. John Weroha et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Metabolically healthy but obese individuals
- (2008) Antony D Karelis LANCET
- Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
- (2008) Iris Shai et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started